Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.840
+0.080 (2.13%)
Jan 22, 2025, 2:07 PM EST - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $38.94 million as of January 22, 2025. Its market cap has increased by 52.86% in one year.
Market Cap
38.94M
Enterprise Value
23.77M
1-Year Change
52.86%
Ranking
Category
Stock Price
3.84
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $38.94M, a decrease of -55.35%. That is a compound annual growth rate of -5.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.58B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |